23andMe Reports Q1 Revenue Drop, Narrows Losses
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
- Latest
- Trending
23andMe's Q1 revenue declines by 34% but narrows losses. Focus on AI and genetic studies drives future growth.
The personalized DNA revolution falls short as a company's stock plummets by 90%. Valued at $3.5 billion, it seeks potential ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.